These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 177817)

  • 1. Hormone receptor mobility and catecholamine binding in membranes. A theoretical model.
    McGuire RF; Barber R
    J Supramol Struct; 1976; 4(2):259-69. PubMed ID: 177817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone receptors.
    Baxter JD; Funder JW
    N Engl J Med; 1979 Nov; 301(21):1149-61. PubMed ID: 226885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of catecholamine activation of adenylate cyclase by the number of active beta-adrenergic receptors: theoretical considerations on the role of receptor diffusion in the cell membrane.
    Swillens S
    J Cyclic Nucleotide Res; 1982; 8(2):71-82. PubMed ID: 6294157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand.
    Costa T; Ogino Y; Munson PJ; Onaran HO; Rodbard D
    Mol Pharmacol; 1992 Mar; 41(3):549-60. PubMed ID: 1312216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated hormone receptors: physiologic and clinical implications.
    Lefkowitz RJ
    N Engl J Med; 1973 May; 288(20):1061-6. PubMed ID: 4144513
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis and application of an equilibrium model for in vitro bioassay systems with three components: receptor, hormone and hormone-binding-protein.
    Barnard R; Wolff RC
    J Theor Biol; 1998 Feb; 190(4):333-9. PubMed ID: 9533868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity studies of leukocytic catecholamine receptors.
    Sokol WN; Beall GN; Kruger SR
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):173-6. PubMed ID: 206516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC; Maullu C; Onali P
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic activation of guanylate cyclase/atrial natriuretic factor receptor by combined effects of ANF and GTP gamma S in plasma membranes of Leydig tumor cells: involvement of G-proteins.
    Khurana ML; Pandey KN
    Arch Biochem Biophys; 1995 Jan; 316(1):392-8. PubMed ID: 7840642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
    Hoyer D; Reynolds EE; Molinoff PB
    Mol Pharmacol; 1984 Mar; 25(2):209-18. PubMed ID: 6142414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
    Graeser D; Neubig RR
    Mol Pharmacol; 1993 Mar; 43(3):434-43. PubMed ID: 8095695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunology of beta-adrenergic receptors: a working model of a hormone-mimicking internal image].
    Strosberg AD; Couraud PO; Delavier-Klutchko C; Durieu-Trautmann O; Schmutz A; Lu BZ
    Ann Immunol (Paris); 1982; 133D(2):191-7. PubMed ID: 6299168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to the anabolic action of androgens by an experimental system.
    Michel G; Baulieu EE
    Environ Qual Saf Suppl; 1976; (5):54-9. PubMed ID: 182485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase.
    Stickle D; Barber R
    Mol Pharmacol; 1989 Sep; 36(3):437-45. PubMed ID: 2550777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
    McKernan RM; Howard MJ; Motulsky HJ; Insel PA
    Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors and acceptors: a necessary distinction in hormone binding studies.
    Birnbaumer L; Pohl SL; Kaumann AJ
    Adv Cyclic Nucleotide Res; 1974; 4(0):239-81. PubMed ID: 4369121
    [No Abstract]   [Full Text] [Related]  

  • 17. The ternary complex model. Its properties and application to ligand interactions with the D2-dopamine receptor of the anterior pituitary gland.
    Wreggett KA; De Léan A
    Mol Pharmacol; 1984 Sep; 26(2):214-27. PubMed ID: 6237254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The problem of identifying the glucagon receptor.
    Rodbell M
    Fed Proc; 1973 Aug; 32(8):1854-8. PubMed ID: 4352450
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of hormone receptor-effector coupling: the beta-adrenergic receptor and adenylate cyclase.
    Lefkowitz RJ; Caron MG; Michel T; Stadel JM
    Fed Proc; 1982 Aug; 41(10):2664-70. PubMed ID: 6125416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
    Alexander RW; Cooper B; Handin RI
    J Clin Invest; 1978 May; 61(5):1136-44. PubMed ID: 207726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.